Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Sells $4M in Equipment to CDC for Chemical Terrorism Testing

NEW YORK, March 25 (GenomeWeb News) - Agilent Technologies will sell $4 million worth of chemical emission testing systems and services, including 30 chromatography/mass spectrometry systems, to the Centers of Disease Control and Prevention, the company said today.

 

The equipment is intended to help the CDC respond to chemical terrorism threats, Agilent said.

 

"These instruments will help guide public health management of chemical incidents by identifying the chemical agent and determining who has been exposed and their level of exposure," said Mike McMullen, vice president and general manager of Agilent's chemical analysis solutions unit.

 

The CDC had previously bought $5 million worth of other life sciences equipment and services from Agilent for its Chemical Terrorism Laboratory Network.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.